GUCY2C hormone suppression links obesity with colorectal cancer
Description: Colorectal cancer is the second leading cause of cancer death in the U.S., and its incidence has a strong epidemiological link to obesity. Here we explore the relationship between obesity, cancer, and hormones regulating the intestinal tumor suppressor GUCY2C. We propose that obesity increases colorectal cancer risk by suppressing the expression of those hormones and silencing GUCY2C, an effect which can be reversed by dietary calorie restriction or oral GUCY2C hormone replacement therapy.
Funder: National Cancer Institute
Funding type: fellowship
Funder scheme: F30
Start date: 2013-07-01
End date: 2016-06-30
Investigator: ERIK BLOMAIN (lead)
Institution: Thomas Jefferson University
Topic: Cancer Risks and Factors
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 15
Funder award ID: F30CA180500
OpenAlex ID: G4201701034
